Kobayashi Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	56,729	62,314	50,873	71,536	96,233	95,024
Short-Term Investments	8,300	8,300	14,872	8,300	8,300	14,022
Cash & Short-Term Investments	65,029	70,614	65,745	79,836	104,533	109,046
Cash Growth	-3.34%	7.41%	-17.65%	-23.63%	-4.14%	15.59%
Receivables	33,418	52,135	49,384	52,984	47,853	55,147
Inventory	26,498	22,752	24,163	22,081	17,678	15,107
Other Current Assets	2,636	3,319	5,176	3,430	2,828	2,589
Total Current Assets	127,581	148,820	144,468	158,331	172,892	181,889
Property, Plant & Equipment	68,337	67,367	67,448	47,665	34,778	22,524
Long-Term Investments	34,751	35,128	28,421	36,083	32,123	33,177
Goodwill	7,503	7,711	9,260	9,655	7,147	7,189
Other Intangible Assets	9,408	9,703	11,414	11,959	6,160	5,469
Long-Term Deferred Tax Assets	5,919	5,264	3,087	2,647	1,750	1,489
Other Long-Term Assets	2	2	1	1	2	1
Total Assets	254,864	275,329	265,368	267,473	255,827	252,554
Accounts Payable	10,607	14,898	14,688	17,305	18,056	17,444
Accrued Expenses	4,417	3,052	2,840	2,705	2,553	2,486
Short-Term Debt	-	-	-	-	-	1
Current Portion of Leases	332	319	343	379	261	169
Current Income Taxes Payable	17,997	33,906	19,376	29,884	25,317	25,662
Other Current Liabilities	8,558	7,962	9,176	5,838	5,622	4,941
Total Current Liabilities	41,911	60,137	46,423	56,111	51,809	50,703
Long-Term Leases	395	359	503	608	531	460
Pension & Post-Retirement Benefits	972	989	1,005	939	2,034	2,019
Long-Term Deferred Tax Liabilities	-	-	1,554	2,594	1,310	1,564
Other Long-Term Liabilities	2,661	2,837	2,413	2,405	2,244	2,209
Total Liabilities	45,939	64,322	51,898	62,657	57,928	56,955
Common Stock	3,450	3,450	3,450	3,450	3,450	3,450
Additional Paid-In Capital	522	522	522	522	522	4,183
Retained Earnings	200,816	204,240	208,240	205,681	194,285	200,534
Treasury Stock	-24,767	-24,767	-24,767	-24,766	-14,482	-23,706
Comprehensive Income & Other	28,894	27,553	26,021	19,929	14,124	11,138
Total Common Equity	208,915	210,998	213,466	204,816	197,899	195,599
Minority Interest	10	9	4	-	-	-
Shareholders' Equity	208,925	211,007	213,470	204,816	197,899	195,599
Total Liabilities & Equity	254,864	275,329	265,368	267,473	255,827	252,554
Total Debt	727	678	846	987	792	630
Net Cash (Debt)	64,302	69,936	64,899	78,849	103,741	108,416
Net Cash Growth	-3.29%	7.76%	-17.69%	-23.99%	-4.31%	15.77%
Net Cash Per Share	865.00	940.78	873.03	1039.65	1344.98	1387.72
Filing Date Shares Outstanding	74.34	74.34	74.34	74.34	76.13	77.28
Total Common Shares Outstanding	74.34	74.34	74.34	74.34	76.01	77.74
Working Capital	85,670	88,683	98,045	102,220	121,083	131,186
Book Value Per Share	2810.31	2838.33	2871.53	2755.17	2603.46	2516.20
Tangible Book Value	192,004	193,584	192,792	183,202	184,592	182,941
Tangible Book Value Per Share	2582.82	2604.08	2593.42	2464.42	2428.40	2353.37

Source: S&P Global Market Intelligence. Standard template. Financial Sources.